[Treatment by sandoven-f in patients with venous affections (author's transl)].
D000328:Adult; D000368:Aged; D003374:Coumarins / Q000627:therapeutic use; D004088:Dihydroergotoxine / Q000627:therapeutic use*; D004338:Drug Combinations; D004341:Drug Evaluation; D004877:Ergoloid Mesylates / Q000627:therapeutic use*; D004929:Esculin / Q000627:therapeutic use*; D005260:Female; D005419:Flavonoids / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012431:Rutin / Q000627:therapeutic use*; D014689:Venous Insufficiency / Q000188:drug therapy*
D003374:Coumarins; D004338:Drug Combinations; D005419:Flavonoids; D004088:Dihydroergotoxine; D004929:Esculin; D012431:Rutin; C005698:dihydroergotoxine mesylate, esculoside, rutoside drug combination; D004877:Ergoloid Mesylates
Sandoven-f-Behandlung ambulanter Patienten mit venösen Erkrankungen